SPOTLIGHT -
May 10th 2024
Respondents said they were concerned about their own mental health or the mental health of another person at higher rates since 2022.
May 8th 2024
The industry must find a way to balance consumer privacy and a return on investment in pharma marketing.
April 29th 2024
Blankenship, vice president of policy initiatives and advocacy at The Academy of Nutrition and Dietetics, discusses how AOMs can play a role in creating strategies to manage the obesity epidemic.
April 24th 2024
April 15th 2024
Greater Than One’s Chief Strategy Officer, Andrew Bast, shares his takeaways from 2024 Rare Disease Summit in Philadelphia, PA.
AbbVie’s Skyrizi Superior to Amgen Plaque Psoriasis Drug, Study Says
Research discovered no new safety signals.
Alkermes Reports $617M in Sales in Second Quarter Earnings Report
Number represents a 124% boost from last year.
Octapharma’s Acquired Coagulation Factor Deficiency Medication Receives FDA Approval
Balfaxar indicated for restoration of blood coagulation.
FDA Offers Approval of Ycanth, Verrica’s Molluscum Treatment
Medicine indicated for adults and pediatric patients aged two and older.
Citing Decline in Glyphosate-Based Product Sales, Bayer Lowers Yearly Outlook
Company now expects around $53 billion in sales for 2023.
European Commission Approves Chronic Kidney Disease Treatment Jardiance
Medicine developed in collaboration between Boehringer Ingelheim and Eli Lilly.
FDA Grants Approval to Tarsus’ Demodex Blepharitis Drug, Xdemvy
Treatment is the first approved for eyelid disease.
Roche, Alnylam Enter RNAi Therapeutic Partnership
Collaboration aims to treat hypertension in patients with high cardiovascular risk.
Biogen Expected to Cut 1,000 Jobs, Earnings Report Says
Layoff comes amid preparations for Leqembi launch.
Balancing Marketability and Risk in a Drug Name
Navigating the challenging landscape of pharmaceutical naming—where a name must meet regulatory approval, clear trademark hurdles, and capture market attention all at once.
Astellas, PeptiDream Announce Protein Degrader Research Collaboration
Agreement to focus on two targets selected by pharma company.
Cognizant, Gilead Announce $800M Partnership Extension
Collaboration intended to enable faster market delivery time for life-threatening disease medications.
FDA Clears Daiichi Sankyo’s Newly Diagnosed Acute Myeloid Leukemia Drug
Approval of Vanflyta comes nearly four years after initial rejection.
Idorsia Reveals Plans to Implement 50 Percent Cost Reduction Initiative
Move likely to be completed by early next year.
Eversana, Amazon Web Service Partner to Accelerate Artificial Intelligence Across Life Sciences Industry
Collaboration aims to help pharmaceuticals drive efficiencies and business value.
Recludix Pharma, Sanofi Enter into Collaboration on Oral STAT6 Inhibitor
Research to focus on multiple immunological and inflammatory indications.
Neurogene, Neoleukin Agree to Company Merger
New organization to focus on advancing genetic medicines.
Scribe Therapeutics, Sanofi Expand Genetic Medicine Partnership
Collaboration to focus on the treatment and prevention of genomic diseases.
Pfizer, Flagship Pioneering to Partner on Development of 10 Single-Asset Programs
$100 million investment to address pharma’s strategic areas of interest.
Novartis Provides Update on Sandoz Spin-Off
Company anticipates launch of a standalone organization.
FDA Approves Boston Scientific’s Deep Brain Stimulation Software
Company aims to utilize technology for efficient Parkinson’s treatment.
Threads, the Twitter Competitor's Impact on Pharma Marketing: Q&A with Justin Chase
An insightful discussion about how Meta's newest social media platform, Threads, is quickly adding another facet to the digital landscape for pharma marketers.
Lilly, LA28 Olympic and Paralympic Games Announce Collaboration Through 2028
Pharma giant to serve as Team USA’s partner in prescription medicine and health equity.
FTC Files Lawsuit to Prevent IQVIA Propel Media Purchase
Agency claims union would threaten a monopoly on programmatic advertising space.
Novartis Announces Acquisition of DTx Pharma
Obtained assets expected to expand capabilities in RNA-based therapeutics.
FTC Requests Further Information on Potential Pfizer Takeover of Seagen
Demand comes among antitrust agency’s recent denial of Amgen’s Horizon buyout.
Eleven Therapeutics, Novo Nordisk Reveal Nucleic Acid Therapy Collaboration
Companies aim to discover novel molecules that promote precise delivery of nucleic acid.
Korro Bio, Frequency Therapeutics Merging into Single Company
Merger aims to advance RNA editing programs.
GlobalVision Releases Text Inspection 2
Cloud-based solution updates pharma regulatory and commercial teams ability to review text and content.
Recursion Receives $50 Million Investment from NVIDIA in AI-Enabled Drug Discovery Partnership
Organizations plan to accelerate development of models for biology and chemistry.